Clinical Trials

NCT02727803 | RECRUITING | PHASE2
100 participants

Personalized NK Cell Therapy in CBT

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2016-05-19
Completion:
2027-05-31
Conditions
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Acute Biphenotypic Leukemia
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Leukemia in Remission
  • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
  • Acute Myeloid Leukemia With Variant MLL Translocations
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • Chemotherapy-Related Leukemia
  • Chronic Myelomonocytic Leukemia
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
  • ISS Stage II Plasma Cell Myeloma
  • ISS Stage III Plasma Cell Myeloma
  • Myelodysplastic Syndrome
  • Myelodysplastic Syndrome With Excess Blasts
  • Myelodysplastic Syndrome With Gene Mutation
  • Myelodysplastic/Myeloproliferative Neoplasm
  • Previously Treated Myelodysplastic Syndrome
  • Recurrent Acute Myeloid Leukemia
  • Recurrent Adult Acute Myeloid Leukemia
  • Recurrent Hodgkin Lymphoma
  • Recurrent Non-Hodgkin Lymphoma
  • Refractory Acute Lymphoblastic Leukemia
  • Refractory Adult Acute Lymphoblastic Leukemia
  • Secondary Acute Myeloid Leukemia
  • Therapy-Related Myelodysplastic Syndrome
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
  • RADIATION
  • PROCEDURE
No Results Yet
NCT02646475 | RECRUITING | PHASE1
26 participants

Metabolic Effects of Angiotensin-(1-7)

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2016-02-29
Completion:
2029-12-31
Conditions
  • Obesity
  • Insulin Resistance
  • Hypertension
  • Metabolic Cardiovascular Syndrome
Interventions
  • DRUG
No Results Yet
NCT02632708 | ACTIVE_NOT_RECRUITING | PHASE1
153 participants

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2015-12-31
Completion:
2018-12-13
Conditions
  • Newly Diagnosed Acute Myeloid Leukemia (AML)
  • Untreated AML
  • AML Arising From Myelodysplastic Syndrome (MDS)
  • AML Arising From Antecedent Hematologic Disorder (AHD)
  • AML Arising After Exposure to Genotoxic Injury
Interventions
  • DRUG
No Results Yet
NCT02254278 | COMPLETED | PHASE2
316 participants

Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2014-10-31
Completion:
2019-06-10
Conditions
  • Stage III Oropharyngeal Squamous Cell Carcinoma
  • Stage IVA Oropharyngeal Squamous Cell Carcinoma
  • Stage IVB Oropharyngeal Squamous Cell Carcinoma
  • Stage IVC Oropharyngeal Squamous Cell Carcinoma
  • Tongue Carcinoma
Interventions
  • DRUG
  • RADIATION
NCT02186847 | COMPLETED | PHASE2
170 participants

Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2014-08-31
Completion:
2019-04-16
Conditions
  • Adenosquamous Lung Carcinoma
  • Bronchioloalveolar Carcinoma
  • Large Cell Lung Carcinoma
  • Lung Adenocarcinoma
  • Non-Small Cell Lung Carcinoma
  • Recurrent Non-Small Cell Lung Carcinoma
  • Squamous Cell Lung Carcinoma
  • Stage IIIA Non-Small Cell Lung Cancer
  • Stage IIIB Non-Small Cell Lung Cancer
Interventions
  • DRUG
  • RADIATION
NCT02106572 | TERMINATED | PHASE3
174 participants

Therapeutic Instillation of Mistletoe

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-22
Start Date:
2015-04-30
Completion:
2026-03-24
Conditions
  • Superficial Bladder Cancer
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page